Literature DB >> 30229829

MicroRNA-791 is an independent prognostic factor of papillary thyroid carcinoma and inhibits the proliferation of PTC cells.

X-B Gao1, C-L Chen, Z-L Tian, F-K Yuan, G-L Jia.   

Abstract

OBJECTIVE: To investigate the significance and possible mechanism of miR-791 in the pathogenesis of papillary thyroid carcinoma (PTC). PATIENTS AND METHODS: The expression of miR-791 in 80 cases of thyroid carcinoma tissues and 80 cases of paracancerous tissues was detected by quantitative Real-time-polymerase chain reaction (qRT-PCR). After miR-791 mimics were transfected into thyroid cancer cells by liposome method, the cell proliferation was detected by Cell Counting Kit-8 (CCK-8) and 5-ethynyl-2'-deoxyuridine (EDU), respectively. Cell cycle was detected by flow cytometry.
RESULTS: The expression of miR-791 in thyroid cancer tissue was significantly lower than that of normal thyroid. The mir-719 expression is positively correlated with the prognosis of thyroid carcinoma. After transfection of miR-791 mimics, the proliferation ability of TPC-1 and HTH83 cells was weakened, and the cell cycle was blocked in the G0/G1 phase. Further study on the underlying mechanism found that after overexpression of miR-791, the expressions of Cyclin D1, CKD6 and CDK4 decreased significantly, while the expression of cyclin inhibitor P21 increased significantly.
CONCLUSIONS: MiR-791 is lowly expressed in thyroid cancer. MiR-791 may inhibit thyroid cancer cell proliferation by blocking thyroid cancer cells in G0/G1 phase, thus participating in the impediment of thyroid cancer development.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30229829     DOI: 10.26355/eurrev_201809_15819

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  MicroRNA‑15b‑5p exerts its tumor repressive role via targeting GDI2: A novel insight into the pathogenesis of thyroid carcinoma.

Authors:  Jidong Zou; Jiantong Qian; Haiyan Fu; Fawen Yin; Wanjun Zhao; Liang Xu
Journal:  Mol Med Rep       Date:  2020-07-15       Impact factor: 2.952

2.  MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer.

Authors:  Jong-Lyul Park; Seon-Kyu Kim; Sora Jeon; Chan-Kwon Jung; Yong-Sung Kim
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

Review 3.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

4.  The Prognostic Value of MicroRNAs in Thyroid Cancers-A Systematic Review and Meta-Analysis.

Authors:  Cristina Alina Silaghi; Vera Lozovanu; Horatiu Silaghi; Raluca Diana Georgescu; Cristina Pop; Anca Dobrean; Carmen Emanuela Georgescu
Journal:  Cancers (Basel)       Date:  2020-09-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.